Strontium 89 therapy for the palliation of pain due to osseous metastases

RG Robinson, DF Preston, M Schiefelbein, KG Baxter - Jama, 1995 - jamanetwork.com
Objective.—To present the current state of systemic radiopharmaceutical therapy for the
palliation of pain in individuals with metastatic cancer and to evaluate the palliative effect
and degree of hemotoxicity of strontium chloride 89 (89 Sr) in patients with painful
osteoblastic metastases primarily from prostate and breast cancer. Data Sources and Study
Selection.—A MEDLINE search through December 1994 was performed to identify English-
language studies that met the following criteria. All eligible studies reported treatment of …